Literature DB >> 28674048

In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods.

Henry S Heine1, Lynda Miller2, Stephanie Halasohoris2, Bret K Purcell2.   

Abstract

In vitro susceptibilities for 47 antibiotics were determined in 30 genetic diverse strains of Francisella tularensis by the broth microdilution method following Clinical and Laboratory Standards Institute (CLSI) methods. The F. tularensis strains demonstrated susceptibility to aminoglycosides, fluoroquinolones, and tetracyclines. There was a distinct difference in macrolide susceptibilities between A and B type strains, as has been noted previously. The establishment and comparison of antibiotic susceptibilities of a diverse but specific set of F. tularensis strains by standardized methods and the establishment of population ranges and MIC50/90 values provide reference information for assessing new antibiotic agents and a baseline to monitor any future emergence of resistance, whether natural or intentional.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Francisella tularensis; antibiotics; susceptibility testing

Mesh:

Substances:

Year:  2017        PMID: 28674048      PMCID: PMC5571322          DOI: 10.1128/AAC.00612-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.

Authors:  Sandra K Urich; Jeannine M Petersen
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

2.  Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.

Authors:  Herbert Tomaso; Sascha Al Dahouk; Erwin Hofer; Wolf D Splettstoesser; Thomas M Treu; Manfred P Dierich; Heinrich Neubauer
Journal:  Int J Antimicrob Agents       Date:  2005-10       Impact factor: 5.283

3.  The class A β-lactamase FTU-1 is native to Francisella tularensis.

Authors:  Nuno T Antunes; Hilary Frase; Marta Toth; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

Review 4.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

5.  In vitro susceptibility of isolates of Francisella tularensis from Turkey.

Authors:  Selçuk Kiliç; Bekir Celebi; Bülent Acar; Mehmet Ataş
Journal:  Scand J Infect Dis       Date:  2012-12-18

6.  Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis.

Authors:  Anders Johansson; Jason Farlow; Pär Larsson; Meghan Dukerich; Elias Chambers; Mona Byström; James Fox; May Chu; Mats Forsman; Anders Sjöstedt; Paul Keim
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

7.  Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents.

Authors:  O Scheel; T Hoel; T Sandvik; B P Berdal
Journal:  APMIS       Date:  1993-01       Impact factor: 3.205

8.  In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.

Authors:  H Syrjälä; R Schildt; S Räisäinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

9.  Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth.

Authors:  C N Baker; D G Hollis; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

10.  In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.

Authors:  Anders Johansson; Sandra K Urich; May C Chu; Anders Sjöstedt; Arne Tärnvik
Journal:  Scand J Infect Dis       Date:  2002
View more
  6 in total

1.  Pharyngeal tularemia acquired in an urban setting in Canada.

Authors:  Fiona Vickers; Andrew Walkty; Yoav Keynan
Journal:  CMAJ       Date:  2022-05-24       Impact factor: 16.859

2.  Mutational Switch-Backs Can Accelerate Evolution of Francisella to a Combination of Ciprofloxacin and Doxycycline.

Authors:  Heer H Mehta; David Ibarra; Christopher J Marx; Craig R Miller; Yousif Shamoo
Journal:  Front Microbiol       Date:  2022-05-09       Impact factor: 6.064

3.  Antimicrobial Susceptibility Test for the Determination of Resistant and Susceptible S. aureus and Enterococcus spp. Using a Multi-Channel Surface Plasmon Resonance Device.

Authors:  Gulsum Ucak Ozkaya; Muhammed Zeki Durak; Isin Akyar; Onur Karatuna
Journal:  Diagnostics (Basel)       Date:  2019-11-15

Review 4.  Genetic Determinants of Antibiotic Resistance in Francisella.

Authors:  Stephen J Kassinger; Monique L van Hoek
Journal:  Front Microbiol       Date:  2021-05-12       Impact factor: 5.640

5.  Serendipitous Treatment of Tularemia in Pregnancy.

Authors:  Joyce J Johnsrud; Carolyn Rebecca Smith; Robert W Bradsher
Journal:  Open Forum Infect Dis       Date:  2019-09-24       Impact factor: 3.835

6.  Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness.

Authors:  Fabrice V Biot; Beth A Bachert; Kevin D Mlynek; Ronald G Toothman; Galina I Koroleva; Sean P Lovett; Christopher P Klimko; Gustavo F Palacios; Christopher K Cote; Jason T Ladner; Joel A Bozue
Journal:  Front Microbiol       Date:  2020-10-30       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.